Noncompetitive inhibitor, enzyme kinetics

Because noncompetitive inhibitors bind to both the free enzyme and the ES complex, or subsequent species in the reaction pathway, we would expect these molecules to exert a kinetic effect on the E + S —> ES" process, thus effecting the apparent values of both VmdX/KM (influenced by both the K and al, terms) and Vmax (influenced by the aK term). This is reflected in the velocity equation for noncompetitive inhibition ... 

In this chapter we described the thermodynamics of enzyme-inhibitor interactions and defined three potential modes of reversible binding of inhibitors to enzyme molecules. Competitive inhibitors bind to the free enzyme form in direct competition with substrate molecules. Noncompetitive inhibitors bind to both the free enzyme and to the ES complex or subsequent enzyme forms that are populated during catalysis. Uncompetitive inhibitors bind exclusively to the ES complex or to subsequent enzyme forms. We saw that one can distinguish among these inhibition modes by their effects on the apparent values of the steady state kinetic parameters Umax, Km, and VmdX/KM. We further saw that for bisubstrate reactions, the inhibition modality depends on the reaction mechanism used by the enzyme. Finally, we described how one may use the dissociation constant for inhibition (Kh o.K or both) to best evaluate the relative affinity of different inhibitors for ones target enzyme, and thus drive compound optimization through medicinal chemistry efforts. 

Figure 8.7 The kinetic effects of a non-competitive inhibitor. The effect of a noncompetitive inhibitor is not reversed by high concentrations of substrate and the enzyme reaction shows a reduced value for the maximum velocity. The enzyme remaining is unaltered and gives the same value for the Michaelis constant as originally shown by the uninhibited enzyme.

El to E4 are irreversible enzymes that follow Michaelis-Menten kinetics. Ei and E2 are inhibited by the noncompetitive inhibitors li and I2. Concentrations of Xi are held constant. Inputs concentrations of E and E. Output steady-state concentration of A. The concentrations of the species marked with ( ) are fixed. 

Most enzyme inhibitors act reversibly—i. e., they do not cause any permanent changes in the enzyme. However, there are also irreversible inhibitors that permanently modify the target enzyme. The mechanism of action of an inhibitor—its inhibition type—can be determined by comparing the kinetics (see p.92) of the inhibited and uninhibited reactions (B). This makes it possible to distinguish competitive inhibitors (left) from noncompetitive inhibitors (right), for example. Allosteric inhibition is particularly important for metabolic regulation (see below). 

A Lineweaver-Burk plot of enzyme kinetics in the presence and absence of a noncompetitive inhibitor is shown in Figure E5.5. Umax in the presence of a noncompetitive inhibitor is decreased, but KM is unaffected. The effect of a competitive inhibitor on the direct linear plot is shown in Figure E5.6. 

Inhibition kinetics are included in the second category of assay applications. An earlier discussion outlined the kinetic differentiation between competitive and noncompetitive inhibition. The same experimental conditions that pertain to evaluation of Ku and Vmax hold for A) estimation. A constant level of inhibitor is added to each assay, but the substrate concentration is varied as for Ku determination. In summary, a study of enzyme kinetics is approached by measuring initial reaction velocities under conditions where only one factor (substrate, enzyme, cofactor) is varied and all others are held constant. 

FIGURE 4.14 Effect of a pure noncompetitive, reversible inhibitor on enzyme kinetics... 

Substances that cause enzyme-catalyzed reactions to proceed more slowly are termed inhibitors, and the phenomenon is termed inhibition. When an enzyme is subject to inhibition, the reaction still may obey Michaelis-Menten kinetics but with apparent Km and Vmax values that vary with the inhibitor concentration. If the inhibitor acts only on the apparent Km, it is a competitive inhibitor if it affects only the apparent Vmax, it is a noncompetitive inhibitor and if it affects both constants, it is an uncompetitive inhibitor. 

Figure 8.18. Kinetics of a Noncompetitive Inhibitor. The reaction pathway shows that the inhibitor binds both to free enzyme and to enzyme complex. Consequently, cannot be attained, even at high substrate concentrations.

Figure 8.38. Noncompetitive Inhibition Illustrated on a Double-Reciprocal Plot. A double-reciprocal plot of enzyme kinetics in the presence ( and absence of a noncompetitive inhibitor shows thatiT is unaltered and...

All of the azides investigated were time-dependent inhibitors at millimolar concentrations and the inhibition was reversible in each case, with hepatic glutathione 5-transferase proving the most sensitive enzyme. Inhibitor potency appears to depend upon the substrate employed, -heptyl and allyl azides (60) and (62) being the most potent with NBC, and -butyl and -hexyl azide (57) and (59) when DNCB was included in the assay. Kinetic studies, where the GSH and DNCB concentrations were independently varied, indicated that compounds (61),(63) and (64) were noncompetitive inhibitors, while allyl azide (62) and the n-alkyl azides (56)-(60) inhibited the enzyme in a competitive manner. From these observations, the authors speculate that, in a process reminiscent of that known to occur with alkyl and aryl halides, glutathione 5-transferase may catalyse the conjugation of azides with GSH in vivo. 

In textbooks dealing with enzyme kinetics, it is customary to distinguish four types of reversible inhibitions (i) competitive (ii) noncompetitive (iii) uncompetitive and, (iv) mixed inhibition. Competitive inhibition, e.g., given by the product which retains an affinity for the active site, is very common. Non-competitive inhibition, however, is very rarely encountered, if at all. Uncompetitive inhibition, i.e. where the inhibitor binds to the enzyme-substrate complex but not to the free enzyme, occurs also quite often, as does the mixed inhibition, which is a combination of competitive and uncompetitive inhibitions. The simple Michaelis-Menten equation can still be used, but with a modified Ema, or i.e. ... 

Inhibitors structurally related to the substrate may be bound to the enzyme active center and compete with the substrate (competitive inhibition). If the inhibitor is not only bound to the enzyme but also to the enzyme-substrate complex, the active center is usually deformed and its function is thus impaired in this case the substrate and the inhibitor do not compete with each other (noncompetitive inhibition). Competitive and noncompetitive inhibition effect the enzyme kinetics differently. A competitive inhibitor does not change but increases. Km (Fig. 25a) in contrast, noncompetitive inhibition results in an unchanged Km and an increased vmax (Fig. 25b). Some enzymes, e.g. invertase, are inhibited by high product concentration (product inhibition). 

The kinetics of AR inhibition by several inhibitors have been studied the flavonoids quercitrin [28] and axillarin [29], as well as sulindac [111], alrestatin [28], indomethacin [111], and -bromophenylsulphonylhydantoin [84], have been shown to be noncompetitive inhibitors. In addition, epalrestat [90], sorbinil [113, 114], TMG [115], 7-hydroxy-4-oxo-4//-chromene-6-car-boxylic acid [32] and statil [95] were found to exhibit mixed uncompetitive-noncompetitive inhibition. Hence, these and other AR inhibitors [116] do not compete for the substrate-binding site on the enzyme. Furthermore, other studies show that various AR inhibitors do not compete for the nucleotide-cofactor-binding site [114,116]. 

The term should be used for enzymes that display Michaelis-Menten kinetics. Thus, it is not used with allosteric enzymes. Technically, competitive and noncompetitive inhibition are also terms that are restricted to Michaelis-Menten enzymes, although the concepts are applicable to any enzyme. An inhibitor that binds to an allosteric enzyme at the same site as the substrate is similar to a classical competitive inhibitor. One that binds at a different site is similar to a noncompetitive inhibitor, but the equations and the graphs characteristic of competitive and noncompetitive inhibition don t work the same way with an allosteric enzyme. 

Since the first purification of TDC by Noe et al. (177), this protein has been extensively characterized (178-180). TDC is a cytosolic enzyme (35,39,181-183) and consists of two identical subunits (molecular weights of 54 kDa). It showed Michaelis-Menten kinetics ( , 75 /iM) besides tryptophan, it also accepts 5-hydroxy-, 5-fluoro-, 4-fluoro-, and 5-methyltryptophan as substrates. o-Tryptophan acts as a noncompetitive inhibitor, tryptamine as a competitive inhibitor ( 310 /iM) (177). Pen-nings et al. (179) reported that TDC contains two molecules of pyrroloqui-nolinequinone (PQQ) and two molecules of pyridoxal phosphate. Phenylalanine, tyrosine, and l-DOPA are not accepted as substrates in vitro, but in transgenic tobacco plants carrying the Tdc gene, increased tyramine levels were found (184,185). 

Describe the effects of competitive and noncompetitive inhibitors on the kinetics of enzyme reactions. Apply kinetic measurements and analysis to determine the nature of an inhibitor. 

Pure noncompetitive inhibition (decrease in V ax with no change in K ) is seldom observed in enzyme kinetics studies, except in the case of very small inhibitors, such as protons, metal ions, and small anions. For noncompetitive... 

Fig. 5.14 Scheme of the kinetics of reaction S Pj + P2 (Pi competitive inhibitor P2 noncompetitive inhibitor S substrate, uncompetitive inhibitor), and enzyme inactivation according to a two-stage series mechanism... 

Such is the case in certain reactions catalyzed by enzymes. The type of inhibition considered thus far can be called competitive inhibition the inhibitor competes with the reactant (called substrate S in enzyme kinetics) for the same active centers. But there also exists a different kind of inhibition called noncompetitive inhibition. A noncompetitive inhibitor D is one that combines with the enzyme E at a site which is different from that which combines with the substrate S. The complex ED between enzyme and inhibitor is then still able to combine further with a substrate molecule but the tertiary complex EDS thus formed is unreactive. If the rate-determining step of the reaction is the decomposition of the complex between enzyme E and substrate S, the sequence with noncompetitive inhibition can be represented as ... 

Competitive and noncompetitive inhibitions change enzyme kinetics differently. A competitive inhibitor does not change Vmax (maximum velocity) but increases K a noncompetitive inhibitor decreases Vmax and fCm remains unchanged. 

Figure 5.10. Demonstration of the four basic types of inhibitions of enzyme kinetics in Lineweaver-Burk plots (see Fig. 4.24c) (a) competitive, (b) noncompetitive, (c) uncompetitive, and (d) substrate inhibition. The parameters and can be estimated from the intercepts and slope of the line with p — 0, where p = inhibitor concentration.

Interaction matrix this matrix is suggested to identify the different interactions that can exist between compounds and enzymes in the process. In this case, the reaction structure defined in the previous step is useful to visuahze and classify those relationships that can happen with a higher degree of probabihty. Similar ideas about the interaction between compounds can be found in the scientific literature or from experimental experience in the laboratory. In order to build the matrix, the compounds involved in the process (i.e., substrates, intermediates, by-products, products, etc.) are arranged in rows (i.e.. A, B, C,...), and the enzymes E ) are arranged in columns (for i = 1, 2, 3,...). In this way, the matrix is filled defining the relationship between each compound and enzyme in turn, that is, (S) for substrate, (P) for product, (I) for inhibitor, or (X) when there is no interaction between one compound and one enzyme. This compiled information is extremely useful to make decisions about the relevant terms or kinetic parameters that must be added or removed from the reaction rate expressions and process model. The position of the new term/parameter in the final expression is defined by the enzyme kinetic mechanism which shows how the compound inhibits the enzyme, for example, competitive, uncompetitive, noncompetitive, or mixed inhibition. 

---